Mystery of the ‘sailing stones' of Racetrack Playa: how San Diego scientists solved the enigma
This phenomenon led to various theories about their movement—from alien interference to magnetic anomalies. However, a groundbreaking study led by researchers from the Scripps Institution of Oceanography at UC San Diego eventually uncovered the natural forces behind this geological mystery.
In 2014, a team of scientists, including paleobiologist Richard Norris, his cousin James Norris and planetary scientist Ralph Lorenz, set up an ambitious experiment to observe the movement of these stones firsthand. They equipped 15 rocks with GPS trackers and established a high-resolution weather station at the southern end of Racetrack Playa. Their goal, according to the researchers, was to capture the rare conditions under which the stones move.
Hike to the world's largest wooden trestle bridge in Southern California
At last, a breakthrough occurred. After a series of wet winter storms, the playa was covered with a thin later of water, which froze overnight into a delicate sheet of ice. The following day, light winds caused the ice to break into large panels, which, driven by wind, moved the rocks across the playa. The GPS devices recorded the movement of the rocks, confirming that the ice sheets were indeed propelling them across the surface of the desert floor.
This phenomenon, known as 'ice shove,' is common in polar regions, according to scientists, but had never been observed in such a desert environment before. This study revealed that the combination of water, ice and wind creates ideal conditions for the stones to move. The ice forms a thin, floating layer that, when broken up by winds, pushes the rocks across the soft, muddy surface, leaving behind their trails in the desert.
Borrow a dead animal or fossil from this SoCal museum — no, seriously
The finding of their study have been published in the journal PLOS ONE. It provides a scientific explanation for the marvel that had puzzled researchers and desert dwellers alike for over a century — and it's all thanks to those San Diego-based researchers.
For those who wish to check out the 'sailing stones' in person, head to Death Valley National Park. Officials with the National Park Foundation have directed visitors to drive two miles south of the Grandstand parking area to the find the stones.
'While the precise location of the 'sailing stones' is always changing, you can usually get the best view by walking about a half-mile toward the southeast corner of the playa,' the park officials explained.
While the scientific community has unraveled the mystery, the allure of these moving rocks continues to inspire wonder and curiosity.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
an hour ago
- Associated Press
CELFULL Unveils Celfavor NADH Microcapsules: A Breakthrough in Stability That Reshapes the Anti-Aging Industry
CORAL SPRINGS, FL / ACCESS Newswire / July 4, 2025 / CELFULL, a biotechnology company with over 25 years of expertise in anti-aging science, has announced a major breakthrough in longevity innovation: the global launch of Celfavor® NADH Microcapsules, a patented delivery system that resolves the century-long challenge of NADH instability. Journal papers related to NADH This revolutionary technology-protected by seven international invention patents across the U.S., China, Japan, Canada, and South Korea-delivers unprecedented improvements in stability, bioavailability, and targeted delivery, marking a new era in anti-aging therapeutics known as the 'Microcapsule Age.' To accelerate research across the globe, CELFULL has also launched its Global Research Sharing Program, offering free access to the Celfavor® NADH raw material to scientific institutions worldwide. Celfavor®NADH The only effective NADH - Celfavor ® NADH 'The discovery of the therapeutic effect of stabilized NADH is more important to humankind than the discovery of antibiotics.' noted Nobel Laureate Sir John Eccles, underscoring the importance of this innovation. NADH stands for 'nicotinamide adenine dinucleotide (NAD) + hydrogen (H), often dubbed the 'King of Anti-Aging Molecules,' plays a central role in mitochondrial energy production, antioxidant defense, and the activation of longevity proteins. However, its inherent instability-sensitive to heat, light, oxygen, and stomach acid-has severely limited its clinical applications. Conventional NADH degrades by over 70% in one month at room temperature and must be stored at -20°C, making practical use difficult. 7 patents have been certified CELFULL's research team, led by its AI-powered Multi-Target Anti-Aging Institute, spent over a decade solving this problem. The result: Celfavor® NADH Microcapsules, a proprietary technology featuring 250-350μm microcapsules that protect NADH with a multi-core soluble shell made from food-grade materials. In stability tests simulating harsh conditions (40°C / 75% RH), traditional NADH retained only 3.5% of its activity after six months. By contrast, Celfavor® NADH maintained 98.3% activity-demonstrating over 6x shelf-life extension, even without refrigeration or light shielding. The stability of Celfavor® NADH microspheres The Celfavor® NADH Microcapsule system delivers innovation across four dimensions: 1. Enhanced Stability: Microcapsules shield NADH from air, moisture, light, and stomach acid, preserving its full potency in gastrointestinal conditions for up to 4 hours. 2. Targeted Release: Using AI-optimized wall material, the system enables 'zero release in the stomach and sustained release in the intestine.' Simulated intestinal studies show 24-hour continuous release, extending absorption time by 5-8x. 3. Superior Bioavailability: In human trials, a daily dose of 40mg led to a 98% increase in blood NAD⁺ levels, a 3.2x improvement over regular NADH. Performance also surpassed other NAD⁺ precursors like NMN and NR. 4. Formulation Flexibility: Unlike unstable NADH, Celfavor® NADH can be safely co-formulated with vitamins, coenzymes, or peptides in single or multi-ingredient capsules. Celfavor ® NADH microsphere advanced technology surpasses others Celfavor® NADH Microcapsules have been granted seven invention patents and passed all 12 safety evaluations, including cytotoxicity and long-term toxicity tests. It is currently the only NADH raw material globally to pass full-spectrum safety certification. The only globally certified raw material for toxicology and safety experiments 'We are not just creating better products-we are building a platform for the future of longevity,' said Dr. Juliane Hitzel, CEO of CELFULL. 'With this microcapsule technology, we're launching new delivery systems for vitamins, peptides, and more. And by sharing our raw materials with global researchers, we're fostering a collaborative ecosystem that accelerates anti-aging science.' From solving the NADH stability problem to advancing intelligent delivery systems, CELFULL's innovation signals a major milestone in human longevity science. As the Celfavor® NADH Microcapsule technology rolls out globally, the anti-aging industry enters a new chapter-one defined by precision, efficiency, and collaboration. For business cooperation or research partnerships, please contact: [email protected] | Email: [email protected] Website: SOURCE: CELFULL press release
Yahoo
3 hours ago
- Yahoo
CELFULL Unveils Celfavor NADH Microcapsules: A Breakthrough in Stability That Reshapes the Anti-Aging Industry
CORAL SPRINGS, FL / / July 4, 2025 / CELFULL, a biotechnology company with over 25 years of expertise in anti-aging science, has announced a major breakthrough in longevity innovation: the global launch of Celfavor® NADH Microcapsules, a patented delivery system that resolves the century-long challenge of NADH instability. Journal papers related to NADH This revolutionary technology-protected by seven international invention patents across the U.S., China, Japan, Canada, and South Korea-delivers unprecedented improvements in stability, bioavailability, and targeted delivery, marking a new era in anti-aging therapeutics known as the "Microcapsule Age." To accelerate research across the globe, CELFULL has also launched its Global Research Sharing Program, offering free access to the Celfavor® NADH raw material to scientific institutions worldwide. Celfavor®NADH The only effective NADH - Celfavor ® NADH "The discovery of the therapeutic effect of stabilized NADH is more important to humankind than the discovery of antibiotics." noted Nobel Laureate Sir John Eccles, underscoring the importance of this innovation. NADH stands for "nicotinamide adenine dinucleotide (NAD) + hydrogen (H), often dubbed the "King of Anti-Aging Molecules," plays a central role in mitochondrial energy production, antioxidant defense, and the activation of longevity proteins. However, its inherent instability-sensitive to heat, light, oxygen, and stomach acid-has severely limited its clinical applications. Conventional NADH degrades by over 70% in one month at room temperature and must be stored at -20°C, making practical use difficult. 7 patents have been certified CELFULL's research team, led by its AI-powered Multi-Target Anti-Aging Institute, spent over a decade solving this problem. The result: Celfavor® NADH Microcapsules, a proprietary technology featuring 250-350μm microcapsules that protect NADH with a multi-core soluble shell made from food-grade materials. In stability tests simulating harsh conditions (40°C / 75% RH), traditional NADH retained only 3.5% of its activity after six months. By contrast, Celfavor® NADH maintained 98.3% activity-demonstrating over 6x shelf-life extension, even without refrigeration or light shielding. The stability of Celfavor® NADH microspheres The Celfavor® NADH Microcapsule system delivers innovation across four dimensions: 1. Enhanced Stability: Microcapsules shield NADH from air, moisture, light, and stomach acid, preserving its full potency in gastrointestinal conditions for up to 4 hours. 2. Targeted Release: Using AI-optimized wall material, the system enables "zero release in the stomach and sustained release in the intestine." Simulated intestinal studies show 24-hour continuous release, extending absorption time by 5-8x. 3. Superior Bioavailability: In human trials, a daily dose of 40mg led to a 98% increase in blood NAD⁺ levels, a 3.2x improvement over regular NADH. Performance also surpassed other NAD⁺ precursors like NMN and NR. 4. Formulation Flexibility: Unlike unstable NADH, Celfavor® NADH can be safely co-formulated with vitamins, coenzymes, or peptides in single or multi-ingredient capsules. Celfavor ® NADH microsphere advanced technology surpasses others Celfavor® NADH Microcapsules have been granted seven invention patents and passed all 12 safety evaluations, including cytotoxicity and long-term toxicity tests. It is currently the only NADH raw material globally to pass full-spectrum safety certification. The only globally certified raw material for toxicology and safety experiments "We are not just creating better products-we are building a platform for the future of longevity," said Dr. Juliane Hitzel, CEO of CELFULL. "With this microcapsule technology, we're launching new delivery systems for vitamins, peptides, and more. And by sharing our raw materials with global researchers, we're fostering a collaborative ecosystem that accelerates anti-aging science." From solving the NADH stability problem to advancing intelligent delivery systems, CELFULL's innovation signals a major milestone in human longevity science. As the Celfavor® NADH Microcapsule technology rolls out globally, the anti-aging industry enters a new chapter-one defined by precision, efficiency, and collaboration. For business cooperation or research partnerships, please contact:maggie@ | Email: maggie@ SOURCE: CELFULL View the original press release on ACCESS Newswire Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
5 hours ago
- Yahoo
Rocket Lab Stock Soars Higher as Neutron's Maiden Flight Nears
Rocket Lab Corp. RKLB is currently on the cusp of a transformative milestone with its highly anticipated Neutron rocket approaching its maiden flight in the second half of 2025. To expand beyond its small-launcher Electron and capture the medium-lift payload market, while positioning itself to compete with heavy-lift providers like SpaceX, Rocket Lab launched the Neutron program. This medium-class, reusable vehicle, with a potential payload capacity of approximately 15,000 kg, aims to offer flexible, cost-effective access to space for a wide range of customers, including satellite constellations, government missions, and commercial payloads. To this end, it is imperative to mention that in May 2025 Rocket Lab announced that it will launch its Neutron rocket for the U.S. Air Force Research Laboratory for a Rocket Cargo mission to support point-to-point cargo transportation, establishing a new era of commercial launch capability to advance global defense logistics for the nation. Earlier in February, the company revealed details about the ocean landing platform, a modified barge, for Neutron missions returning to Earth. Customized modification is currently ongoing on this barge, including autonomous ground support equipment to capture and secure the landed Neutron, blast shielding to protect equipment during Neutron landings, and station-keeping thrusters for precise positioning. These announcements implying consistent progress in the Neutron program have bolstered investor confidence, reflected in Rocket Lab's share price performance. While the company's year-to-date price increase has been modest, the past three months have seen a sharper uptick, underscoring growing optimism around Neutron's prospects as new milestones mentioned above are achieved. RKLB's shares gained 40% year to date, while the same soared 103.6% over the past three months. The space launch services market has been witnessing solid growth trends driven by surging demand for satellite constellations, increasing government and defense investments, and the growing need for low-cost, reliable access to space to support telecommunications, Earth observation, and national security missions. Therefore, investors interested in this business realm may keep RKLB along with other industry players like Boeing BA and Lockheed Martin LMT in their watchlist, which already enjoy an established footprint in the space launch market. Boeing's products have powered human space exploration for six decades now. The company is the prime contractor for the design, development and production of the core stage, upper stages and flight avionics suite used in NASA's Space Launch System, the only proven deep-space optimized, super-heavy lift rocket built to carry astronauts and cargo farther and faster than any rocket in history. Lockheed Martin is another space stock that has contributed significantly to various space missions with its breakthrough technologies. It is the prime contractor involved in the construction of Orion, the spacecraft that will carry the crew of four astronauts in the Artemis II lunar mission. Shares of RKLB have gained 630.8% in the past year compared with the industry's 50.9% growth. Image Source: Zacks Investment Research With respect to valuation, the company trades at a premium. RKLB currently trades at a forward 12-month Price/Sales of 22.49X compared with its industry's average of 10.06X. Image Source: Zacks Investment Research The Zacks Consensus Estimates for RKLB's 2025 and 2026 loss have improved over the past 60 days. Image Source: Zacks Investment Research RKLB stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA) : Free Stock Analysis Report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Rocket Lab Corporation (RKLB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio